Skip to main content
. Author manuscript; available in PMC: 2015 Mar 31.
Published in final edited form as: Gastrointest Endosc. 2012 Feb;75(2):332–338. doi: 10.1016/j.gie.2011.10.007

Table 3.

Tumor objective response

N=50
Best response (n [%])
Complete response 1 (2)
Partial response 3 (6)
Minor response 4 (8)
Stable disease 12 (24)
Progressive disease 19 (38)
Not applicable/nondiagnostic 8 (16)